Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXEH3N
|
||||
| Drug Name |
Cyclohexanecarboxylic acid [(S)-1-formyl-2-(1H-indol-3-yl)-ethyl]-amide
|
||||
| Synonyms |
CHEMBL335942
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C18H22N2O2
|
||||
| Canonical SMILES |
O=C[C@H](Cc1c[nH]c2ccccc12)NC(=O)C3CCCCC3
|
||||
| InChI |
InChI=1S/C18H22N2O2/c21-12-15(20-18(22)13-6-2-1-3-7-13)10-14-11-19-17-9-5-4-8-16(14)17/h4-5,8-9,11-13,15,19H,1-3,6-7,10H2,(H,20,22)/t15-/m0/s1
|
||||
| InChIKey |
JBUOTMSLPJQXBQ-HNNXBMFYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.